This map delineates the detailed profiles of immune cells in the CKD renal microenvironment and reveals the potential value of therapeutic strategies targeting CKD-injured cells, SPP1 macrophages, or molecules involved in their crosstalk. This evidence concerns the gene SPP1 and chronic kidney disease.